Literature DB >> 32240669

Multi-modal imaging reveals differential brain volumetric, biochemical, and white matter fiber responsivity to repeated intermittent ethanol vapor exposure in male and female rats.

Natalie M Zahr1, Aran M Lenart2, Joshua A Karpf2, Keriann M Casey3, Kilian M Pohl4, Edith V Sullivan5, Adolf Pfefferbaum4.   

Abstract

A generally accepted framework derived predominately from animal models asserts that repeated cycles of chronic intermittent ethanol (EtOH; CIE) exposure cause progressive brain adaptations associated with anxiety and stress that promote voluntary drinking, alcohol dependence, and further brain changes that contribute to the pathogenesis of alcoholism. The current study used CIE exposure via vapor chambers to test the hypothesis that repeated episodes of withdrawals from chronic EtOH would be associated with accrual of brain damage as quantified using in vivo magnetic resonance imaging (MRI), diffusion tensor imaging (DTI), and MR spectroscopy (MRS). The initial study group included 16 male (~325g) and 16 female (~215g) wild-type Wistar rats exposed to 3 cycles of 1-month in vapor chambers + 1 week of abstinence. Half of each group (n = 8) was given vaporized EtOH to blood alcohol levels approaching 250 mg/dL. Blood and behavior markers were also quantified. There was no evidence for dependence (i.e., increased voluntary EtOH consumption), increased anxiety, or an accumulation of pathology. Neuroimaging brain responses to exposure included increased cerebrospinal fluid (CSF) and decreased gray matter volumes, increased Choline/Creatine, and reduced fimbria-fornix fractional anisotropy (FA) with recovery seen after one or more cycles and effects in female more prominent than in male rats. These results show transient brain integrity changes in response to CIE sufficient to induce acute withdrawal but without evidence for cumulative or escalating damage. Together, the current study suggests that nutrition, age, and sex should be considered when modeling human alcoholism.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Diffusion tensor imaging; Liver; Magnetic resonance spectroscopy; White matter; behavior; repeated withdrawal

Year:  2020        PMID: 32240669      PMCID: PMC8143804          DOI: 10.1016/j.neuropharm.2020.108066

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  128 in total

1.  Transcallosal white matter degradation detected with quantitative fiber tracking in alcoholic men and women: selective relations to dissociable functions.

Authors:  Adolf Pfefferbaum; Margaret J Rosenbloom; Rosemary Fama; Stephanie A Sassoon; Edith V Sullivan
Journal:  Alcohol Clin Exp Res       Date:  2010-05-07       Impact factor: 3.455

2.  Multiple previous alcohol detoxifications are associated with decreased medial temporal and paralimbic function in the postwithdrawal period.

Authors:  M S George; C C Tenebäck; R J Malcolm; J Moore; L E Stallings; K M Spicer; R F Anton; J C Ballenger
Journal:  Alcohol Clin Exp Res       Date:  1999-06       Impact factor: 3.455

3.  Frontal lobe volume loss observed with magnetic resonance imaging in older chronic alcoholics.

Authors:  A Pfefferbaum; E V Sullivan; D H Mathalon; K O Lim
Journal:  Alcohol Clin Exp Res       Date:  1997-05       Impact factor: 3.455

4.  White matter microstructural recovery with abstinence and decline with relapse in alcohol dependence interacts with normal ageing: a controlled longitudinal DTI study.

Authors:  Adolf Pfefferbaum; Margaret J Rosenbloom; Weiwei Chu; Stephanie A Sassoon; Torsten Rohlfing; Kilian M Pohl; Natalie M Zahr; Edith V Sullivan
Journal:  Lancet Psychiatry       Date:  2014-08-05       Impact factor: 27.083

5.  Neurological, nutritional and alcohol consumption factors underlie cognitive and motor deficits in chronic alcoholism.

Authors:  Rosemary Fama; Anne-Pascale Le Berre; Cheshire Hardcastle; Stephanie A Sassoon; Adolf Pfefferbaum; Edith V Sullivan; Natalie M Zahr
Journal:  Addict Biol       Date:  2017-12-15       Impact factor: 4.280

6.  Impaired decision-making and brain shrinkage in alcoholism.

Authors:  A-P Le Berre; G Rauchs; R La Joie; F Mézenge; C Boudehent; F Vabret; S Segobin; F Viader; P Allain; F Eustache; A-L Pitel; H Beaunieux
Journal:  Eur Psychiatry       Date:  2012-11-24       Impact factor: 5.361

7.  Kindling of withdrawal: a study of craving and anxiety after multiple detoxifications in alcoholic inpatients.

Authors:  Theodora Duka; Julia M Townshend; Kirsty Collier; David N Stephens
Journal:  Alcohol Clin Exp Res       Date:  2002-06       Impact factor: 3.455

8.  Binge Ethanol Consumption Increases Inflammatory Pain Responses and Mechanical and Cold Sensitivity: Tigecycline Treatment Efficacy Shows Sex Differences.

Authors:  Susan E Bergeson; Henry Blanton; Joseph M Martinez; David C Curtis; Caitlyn Sherfey; Brandon Seegmiller; Patrick C Marquardt; Jessica A Groot; Clayton L Allison; Christian Bezboruah; Josée Guindon
Journal:  Alcohol Clin Exp Res       Date:  2016-11-14       Impact factor: 3.455

Review 9.  Animal models of alcohol withdrawal.

Authors:  H C Becker
Journal:  Alcohol Res Health       Date:  2000

10.  The Laboratory Rat: Relating Its Age With Human's.

Authors:  Pallav Sengupta
Journal:  Int J Prev Med       Date:  2013-06
View more
  3 in total

1.  Age differences in brain structural and metabolic responses to binge ethanol exposure in fisher 344 rats.

Authors:  Natalie M Zahr; Edith V Sullivan; Kilian M Pohl; Adolf Pfefferbaum
Journal:  Neuropsychopharmacology       Date:  2020-06-24       Impact factor: 8.294

2.  Jacobian Mapping Reveals Converging Brain Substrates of Disruption and Repair in Response to Ethanol Exposure and Abstinence in 2 Strains of Rats.

Authors:  Qingyu Zhao; Kilian M Pohl; Edith V Sullivan; Adolf Pfefferbaum; Natalie M Zahr
Journal:  Alcohol Clin Exp Res       Date:  2020-11-20       Impact factor: 3.455

Review 3.  The Inferior Colliculus in Alcoholism and Beyond.

Authors:  Tanuja Bordia; Natalie M Zahr
Journal:  Front Syst Neurosci       Date:  2020-12-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.